Search

Displaying results 1141 - 1150 of 10000 in total
  1. Drug

    Ferrous cysteine glycinate

    go.drugbank.com/drugs/DB11197
    Approved

    Mixtures: Enl, Escavite Lq
  2. Drug

    Durvalumab

    go.drugbank.com/drugs/DB11714
    ApprovedInvestigational

    [A192789] Produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cell suspension culture,[L12621] durvalumab is a programmed death-ligand 1 (PD-L1) blocking antibody that works to promote … [L12621] In September 2018, durvalumab was approved by the EMA for the treatment of adult patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), only if PD-L1 is expressed in

    Categories: PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
  3. Drug

    Taurocholic acid

    go.drugbank.com/drugs/DB04348
    Approved

    It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and cholerectic.

    Mixtures: Lax-BO TabCategories: Compounds used in a research, industrial, or household setting
  4. Drug

    Manganese citrate

    go.drugbank.com/drugs/DB14495
    Approved

    Mixtures: Collag-EN
  5. Drug

    Selenious acid

    go.drugbank.com/drugs/DB11127
    Approved

    One study showed efficacy in the prevention of malignancy while utilizing a selenium supplement in humans. … Selenious acid is the acid form of sodium selenite, a form of selenium [L1910]. Selenium is an essential trace element and antioxidant. It is a cofactor metabolic enzyme regulation.

    Mixtures: Formula F L W, Vitamins C Plus E W.beta Carotene and Se
  6. Drug

    Beet

    go.drugbank.com/drugs/DB10640
    Approved

    Beet allergenic extract is used in allergenic testing.

    Mixtures: Anbiser B-HA Hyaluronic Acid Nourishing Conditioner
  7. Drug

    Phosphatidyl serine

    go.drugbank.com/drugs/DB00144
    ApprovedNutraceutical

    PS has been investigated in a small number of double-blind placebo trials and has been shown to increase memory performance in the elderly. … The dietary supplement was originally processed from bovine sources however Prion disease scares in the 1990s outlawed this process, and a soy-based alternative was adopted.

    Mixtures: Enl
  8. Drug

    Digoxin

    go.drugbank.com/drugs/DB00390
    ApprovedInvestigational

    [A178234] Digoxin is classified as a cardiac glycoside and was initially approved by the FDA in 1954. … [L9143] This drug originates from the foxglove plant, also known as the _Digitalis_ plant[T610], studied by William Withering, an English physician and botanist in the 1780s.

    Categories: Compounds used in a research, industrial, or household setting, BSEP/ABCB11 Substrates with a Narrow Therapeutic Index
  9. Drug

    Boceprevir

    go.drugbank.com/drugs/DB08873
    ApprovedWithdrawn

    Boceprevir is an inhibitor of NS3/4A, a serine protease enzyme, encoded by HCV genotypes 1 and 4 [synthesis]. … In a joint recommendation published in 2016, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) do not reccomend Boceprevir in combination

    Categories: NS3/4A Protease Inhibitors, HCV NS3/4A Protease Inhibitors
  10. Drug

    Antithrombin Alfa

    go.drugbank.com/drugs/DB11166
    Approved

    Antithrombin Alfa is a recombinant antithrombin , an anticoagulant, that is used for the prevention of thromboembolic events in patients that have hereditary deficiency of antithrombin in high risk situations

    Categories: Factor Xa Inhibitors